Evaluating the efficacy of harmol in treating herpes simplex virus-induced keratitis

FHS
May 29, 2024
10:06 am

The antiviral efficacy and therapeutic potential of harmol in treating herpes simplex virus type 1 (HSV-1) induced keratitis

PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance | Psychedelic Invest

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel derivatives of

January 11, 2024

FDA authorizes Novavax’s updated Covid-19 vaccine

The Food and Drug Administration on Tuesday authorized Novavax’s updated Covid-19 vaccine, giving Americans seeking to update their protection against the SARS-CoV-2 virus another option.

October 3, 2023

FLT3 Inhibitor Highly Active in Newly Diagnosed Acute Myeloid Leukemia

Patients with newly diagnosed FLT3-mutated acute myeloid leukemia (AML) had a high response rate and prolonged event-free survival (EFS) following treatment with an investigational FLT3

February 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.